维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="PROUDFOOT AE"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus显示文摘	Mack M Proudfoot AE	1999	J Biol Chem1999，274，13：	1
2	The strategy of blocking the chemokine system to combat disease显示文摘	Proudfoot AE Power CA Wells TN	2000	Immunol Rev2000，，177：	1
3	Amelioration of rat adjuvant-induced arthritis by Met-RANTES显示文摘	Shahrara S Proudfoot AE Woods JM	2005	Arthritis Rheum2005，52，：	1
4	Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors显示文摘	Proudfoot AE Buser R Borlat F	1999	J Biol Chem1999，274，32：	1
5	Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice显示文摘	Schuh JM Power CA Proudfoot AE	2002	FASEB J2002，16，10：	1
6	Extension of recombinant human RANES by the retention of the initiating methionine produces a potent antagonist显示文摘	Proudfoot AE Power CA Hoogewerf A J	1996	J Biol Chem1996，271，5：	1
7	Molecular-cloning and functional expression of a novel CC-chemokine receptor cDNA from a human basophilic cell-line 显示文摘	Power CA Meyer A Nemeth K Bacon KB Hoogewerf AJ Proudfoot AE	1995	J Biol Chem1995，270，33：	1
8	Differential effects of CC chemokines on CC chemokine receptor 5 ( CCR5 ) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus 显示文摘	Oppermann M Mack M Proudfoot AE	1999	J Biol Chem1999，274，：	1
9	CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte traf- ficking to inflamed skin 显示文摘	Reiss Y Proudfoot AE Power CA	2001	J Exp Med2001，194，10：	1
10	Ef-fect of a CC chemokine receptor antagonist on collagen in-duced arthritis in DBA/1mice显示文摘	Plater-Zyberk C Hoogewerf AJ Proudfoot AE	1997	Immunol Lett1997，57，13：	1
11	HDL is the major lipoprotein car-rier of plasma F2-isoprostanes显示文摘	Proudfoot JM Barden AE Loke WM	2009	J Lipid Res2009，50，4：	1
12	Treatment of experimental autoimmune encephalomyelitis with the ehemokine receptor antagonist Met-RANTES 显示文摘	Matsui M Weaver J Proudfoot AE	2002	J Neuroimmunol2002，128，12：	1
13	Overcoming hurdles in developing successful drugs targeting chemokine receptors显示文摘	Schall TJ Proudfoot AE	2011	Nat Rev Immunol2011，11，：	1
14	Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antago- nist Met-RANTES 显示文摘	Matsui M Weaver J Proudfoot AE	2002	J Neuroimmunol2002，128，12：	1
15	Anti-ehemokine small molecule drugs: a promising future? 显示文摘	Proudfoot AE Power CA Sehwarz MK	2010	Expert Opin Investig Drugs2010，19，3：	1
16	HDL is the major lipo-protein carrier of plasma F2~isoprostanes 显示文摘	Proudfoot JM Barden AE Loke WM	2009	J Lipid Res2009，50，4：	1
17	Chemokine receptors: muhifaceted therapeutic targets 显示文摘	Proudfoot AE	2002	Nat Rev Immunol2002，2，2：	1
18	Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors 显示文摘	Buser R Borlat F	1999	J Biol Chem1999，274，32：	1
19	Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets显示文摘	Clemetson KJ Clemetson JM Proudfoot AE	2000	Blood2000，96，：	1
20	Inhibition of mono- cyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthri-tis显示文摘	Shahraras D Proudfoot AE Park C	2008	J Immunol2008，180，5：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示